Emerging evidence has shown that Lymphoid enhancer-binding factor 1 (LEF1) expression is highly increased in leukemia and various types of solid cancer, such as lung adenocarcinoma, colorectal cancer, prostate cancer, and malignant melanoma [14]. The gene discussed is LEF1; the disease is prostate cancer.